$40.72
0.020.05%
Last update: Nov 11, 1:06 PM
Novo Nordisk AS
NVONYSE
The average analyst price target for Novo Nordisk is $83.69, 105.5% above the current price. Of 12 analysts, 4 rate it Buy, 6 Hold and 2 Sell. Targets range from $40 to $160. The latest change came on Oct 12, 2026, when BMO Capital lowered its price target on Novo Nordisk from $47 to $40 and kept a Market Perform rating.
Price Target Range — 11 Quarters
Analyst Consensus — 12 Analysts
Rating Trend — Last 9 Months
